Earnings decline despite operational strength: FY2026 guidance midpoint of $3.03 represents a 9% drop from FY2025 adjusted EPS of $3.32, creating a disconnect between management's emphasis on "record" performance and near-term profitability expectations Multi-year growth targets face execution uncertainty: While management extended outlook through FY2029 with 5-7% EBITDA CAGR aspirations, the…

Our analysis rates this filing CAUTIOUS. The elevated concern level reflects a significant disconnect between management's positive messaging about 'record' FY2025 performance and the FY2026 guidance that implies material earnings contraction. The 9% expected decline in adjusted EPS is particularly…

Concern level: HIGH (6.5/10). Key factors: FY2026 adjusted EPS guidance midpoint of $3.03 represents 9% decline from FY2025 actual results of $3.32, signaling material earnings headwinds; Three new risks identified with average severity of 4.3/10, including high-severity earnings guidance concern; AmeriGas subsidiary leverage remains elevated at 4.9x despite improvements, constraining financial…

Notable risk changes: FY2026 earnings guidance midpoint ($3.03) implies 9% decline from FY2025 adjusted EPS of $3.32, despite management highlighting 'record' performance and 5-7% expected EBIT growth; Extended earnings growth outlook to FY2029 with 5-7% CAGR target, but starting from lower FY2026 base creates execution risk over multi-year period; Balance sheet strengthened with UGI Corporation leverage improved to…

The model predicts UGI will outperform the S&P 500 by about 0.0% over 30 days. This is model analysis for research, not investment advice.